-
公开(公告)号:US20160108119A1
公开(公告)日:2016-04-21
申请号:US14977688
申请日:2015-12-22
申请人: UCB PHARMA, S.A.
CPC分类号: C07K16/241 , C07K1/18 , C07K1/36 , C07K2317/14 , C07K2317/55
摘要: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
-
公开(公告)号:US11339214B2
公开(公告)日:2022-05-24
申请号:US16248845
申请日:2019-01-16
申请人: UCB PHARMA, S.A.
摘要: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
-
公开(公告)号:US10189897B2
公开(公告)日:2019-01-29
申请号:US14977688
申请日:2015-12-22
申请人: UCB PHARMA, S.A.
摘要: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
-
公开(公告)号:US20190135909A1
公开(公告)日:2019-05-09
申请号:US16248845
申请日:2019-01-16
申请人: UCB PHARMA, S.A.
摘要: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
-
-
-